VGHAX Mutual Fund

NAV$85.71
Showing top 15 of 109 holdingsSee all 109 holdings(as of Mar 31, 2026)
#Ticker ↕Name ↕Weight ↓Shares ↕Mkt Value ↕Share ChgPROSectorPROIndustryPRO
1LLYEli Lilly And Company9.16%3,658,891$3.37B-Health CarePharmaceuticals
2MRKMerck & Co. Inc.5.83%17,789,747$2.14B-Health CarePharmaceuticals
3AZN:LNAstrazeneca Plc Adr5.27%9,897,175$1.94BProProPro
4JNJJOHNSON AND JOHNSON3.46%5,203,442$1.27BProProPro
5GSK:LNGSK plc3.40%45,301,487$1.25BProProPro
6EWEdwards Lifesciences Corp3.23%14,827,809$1.19BProProPro
7UNHUnited Health Group2.91%3,947,604$1.07BProProPro
8ISRGIntuitive Surgical Inc - Common2.54%2,025,229$933.61MProProPro
9DHRDanaher Corporation2.50%4,836,473$917.00MProProPro
10BSXBoston Sci Com Usd0.012.47%14,461,266$907.44MProProPro
11ABTAbbott Laboratories2.31%8,260,035$848.06MProProPro
12UCB:BRUcb Sa2.27%2,773,167$835.55MProProPro
13ARGX:ASArgenx Se (Brussels Stock Exchange)2.26%1,146,086$831.76MProProPro
14CORCencora Inc2.02%2,363,859$742.58MProProPro
15VRTXVertex Pharmaceuticals Inc1.98%1,628,581$727.23MProProPro
See the other 94 holdings of VGHAX
Every position with sector, industry and share changes, as reported Mar 31, 2026.
Get FundXLS Pro: $29/moFirst 500 subscribers, then $49/mo. Cancel anytime.

VGHAX Mutual Fund All Holdings

VGHAX holdings total 109 positions. The top 10 holdings account for 40.8% of the fund, led by Eli Lilly And Company at 9.2%, Merck & Co. Inc. at 5.8%, Astrazeneca Plc Adr at 5.3%.

VGHAX portfolio concentration is moderate, with the top 10 representing 40.8% of total assets. The largest sector exposure is Health Care at 72.2%.

VGHAX sector allocation provides a detailed breakdown. VGHAX overlap tool shows how holdings compare to other funds in your portfolio.